Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Restructuring Costs (2025)

Tandem Diabetes Care's Restructuring Costs history spans 1 years, with the latest figure at $20.0 million for Q2 2025.

  • For Q2 2025, Restructuring Costs changed N/A year-over-year to $20.0 million; the TTM value through Dec 2025 reached $20.0 million, changed N/A, while the annual FY2025 figure was $20.0 million, N/A changed from the prior year.
  • Restructuring Costs reached $20.0 million in Q2 2025 per TNDM's latest filing.
  • In the past five years, Restructuring Costs ranged from a high of $20.0 million in Q2 2025 to a low of $20.0 million in Q2 2025.